ENANTA PHARMACEUTICALS, INC (ENTA) Shareholders’ equity 2017–2025
ENANTA PHARMACEUTICALS, INC (ENTA) shareholders’ equity at each fiscal year-end, per SEC filings.
$64.7MFY2025 · since FY2017: $301.7M → $64.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $64.7M | -49.8% |
| FY2024 | $128.8M | -40.6% |
| FY2023 | $216.7M | -32.6% |
| FY2022 | $321.3M | -19.6% |
| FY2021 | $399.4M | -12.3% |
| FY2020 | $455.6M | -1.5% |
| FY2019 | $462.5M | +17.5% |
| FY2018 | $393.7M | +30.5% |
| FY2017 | $301.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice